These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man. Böhm RO, van Baak MA, Rahn KH. Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702 [Abstract] [Full Text] [Related]
16. Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man. MacDonald NJ, Hughes DM, Lees KR, Reid JL. Br J Clin Pharmacol; 1990 Jul 24; 30(1):107-13. PubMed ID: 2202384 [Abstract] [Full Text] [Related]
17. Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288. Gohlke P, Schölkens B, Henning R, Urbach H, Unger T. J Cardiovasc Pharmacol; 1989 Jul 24; 14 Suppl 4():S32-6. PubMed ID: 2483426 [Abstract] [Full Text] [Related]
18. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. Brunner DB, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H, Brunner HR, Schelling JL. Br J Clin Pharmacol; 1981 May 24; 11(5):461-7. PubMed ID: 6268131 [Abstract] [Full Text] [Related]